HRP20130958T1 - Supstituirani derivati sulfonamida - Google Patents
Supstituirani derivati sulfonamida Download PDFInfo
- Publication number
- HRP20130958T1 HRP20130958T1 HRP20130958TT HRP20130958T HRP20130958T1 HR P20130958 T1 HRP20130958 T1 HR P20130958T1 HR P20130958T T HRP20130958T T HR P20130958TT HR P20130958 T HRP20130958 T HR P20130958T HR P20130958 T1 HRP20130958 T1 HR P20130958T1
- Authority
- HR
- Croatia
- Prior art keywords
- methoxy
- ethanone
- piperidin
- piperazin
- dimethylphenylsulfonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006046743 | 2006-09-29 | ||
| PCT/EP2007/008417 WO2008040492A1 (de) | 2006-09-29 | 2007-09-27 | Substituierte sulfonamid-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130958T1 true HRP20130958T1 (hr) | 2013-11-22 |
Family
ID=38740241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130958TT HRP20130958T1 (hr) | 2006-09-29 | 2007-09-27 | Supstituirani derivati sulfonamida |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20080153843A1 (OSRAM) |
| EP (2) | EP2383267A1 (OSRAM) |
| JP (1) | JP5405303B2 (OSRAM) |
| KR (1) | KR20090079914A (OSRAM) |
| CN (1) | CN101553481A (OSRAM) |
| AU (1) | AU2007304475B2 (OSRAM) |
| BR (1) | BRPI0714764A2 (OSRAM) |
| CA (1) | CA2664810A1 (OSRAM) |
| CO (1) | CO6170358A2 (OSRAM) |
| CY (1) | CY1114669T1 (OSRAM) |
| DK (1) | DK2066659T3 (OSRAM) |
| ES (1) | ES2436020T3 (OSRAM) |
| HR (1) | HRP20130958T1 (OSRAM) |
| IL (1) | IL197814A0 (OSRAM) |
| MX (1) | MX2009003382A (OSRAM) |
| NO (1) | NO20091299L (OSRAM) |
| NZ (1) | NZ575566A (OSRAM) |
| PL (1) | PL2066659T3 (OSRAM) |
| PT (1) | PT2066659E (OSRAM) |
| RU (1) | RU2462464C2 (OSRAM) |
| SI (1) | SI2066659T1 (OSRAM) |
| WO (1) | WO2008040492A1 (OSRAM) |
| ZA (1) | ZA200902915B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007020493A1 (de) * | 2007-04-30 | 2008-11-06 | Grünenthal GmbH | Substituierte Amid-Derivate |
| EP2229394A1 (en) * | 2008-01-17 | 2010-09-22 | Grünenthal GmbH | Substituted sulfonamide derivatives |
| EP2262792A1 (de) * | 2008-04-08 | 2010-12-22 | Grünenthal GmbH | Substituierte sulfonamid-derivate |
| TW201022267A (en) | 2008-10-23 | 2010-06-16 | Gruenenthal Gmbh | Substituierte pyrimidin-und triazin-derivate |
| JP2012506883A (ja) | 2008-10-29 | 2012-03-22 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換されたスピロアミン |
| TW201020247A (en) | 2008-11-06 | 2010-06-01 | Gruenenthal Gmbh | Substituierte disulfonamide |
| TW201031665A (en) | 2009-02-04 | 2010-09-01 | Gruenenthal Gmbh | Substituted indole-compound |
| TW201030007A (en) | 2009-02-06 | 2010-08-16 | Gruenenthal Gmbh | Substituted spiro-amides as b1r modulators |
| TW201035102A (en) | 2009-03-04 | 2010-10-01 | Gruenethal Gmbh | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| TW201038572A (en) | 2009-03-25 | 2010-11-01 | Gruenenthal Gmbh | Substituted spiro-amide compounds |
| BRPI1010649A2 (pt) | 2009-06-08 | 2016-06-07 | Gruenenthal Gmbh | benzimidazóis, benzotiazóis e benzoxazoles substituídos. |
| RU2012146986A (ru) | 2010-04-05 | 2014-05-20 | Сионоги Энд Ко., Лтд. | Цефемовые соединения, содержащие катехольную группу |
| WO2012028331A1 (en) | 2010-09-03 | 2012-03-08 | Grünenthal GmbH | Substituted tetrahydropyrrolopyrazine derivatives |
| TW201217312A (en) | 2010-09-22 | 2012-05-01 | Gruenenthal Gmbh | Substituted benzamide compounds |
| CN106748627A (zh) * | 2016-11-14 | 2017-05-31 | 苏州市罗森助剂有限公司 | 一种一锅法制备3,5‑二甲基溴苯的方法 |
| CA2965062A1 (en) * | 2017-04-25 | 2018-10-25 | Nova Chemicals Corporation | Complex comprising odh unit with integrated oxygen separation module |
| KR101798840B1 (ko) | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
| CN109810031B (zh) * | 2017-11-21 | 2023-10-17 | 乳源瑶族自治县东阳光生物科技有限公司 | 非罗考昔中间体的制备方法 |
| WO2023028056A1 (en) | 2021-08-24 | 2023-03-02 | Genentech, Inc. | 3-amino piperidyl sodium channel inhibitors |
| CN116253667B (zh) * | 2022-12-27 | 2024-08-30 | 煤炭科学研究总院有限公司 | 一种聚集诱导发光材料及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT835659E (pt) * | 1996-10-14 | 2005-03-31 | Aventis Pharma Gmbh | Utilizacao de antagonistas nao petidicos da bradiquinina para a preparacao de medicamentos para o tratamento e prevencao da doenca de alzheimer |
| FR2790260B1 (fr) * | 1999-02-26 | 2001-05-04 | Fournier Ind & Sante | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| US20040171614A1 (en) * | 2002-02-06 | 2004-09-02 | Schering-Plough Corporation | Novel gamma secretase inhibitors |
| TW200302717A (en) * | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
| US7256186B2 (en) * | 2002-02-06 | 2007-08-14 | Schering Corporation | Gamma secretase inhibitors |
| CA2522084A1 (en) * | 2003-04-10 | 2004-10-28 | Amgen Inc. | Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| WO2005068448A1 (en) * | 2003-08-29 | 2005-07-28 | Ionix Pharmaceuticals Limited | Sulfonamides antagonising n-type calcium channels |
| KR20060044523A (ko) * | 2004-03-23 | 2006-05-16 | 마츠시타 덴끼 산교 가부시키가이샤 | 기기 설치 장소 설정 시스템, 기기 제어 장치, 전기 기기,기기 설치 장소 설정 방법 및 기기 설치 장소 설정프로그램을 기록한 컴퓨터 판독 가능한 기록 매체 |
| WO2005113542A2 (en) * | 2004-05-20 | 2005-12-01 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
| WO2006000020A1 (en) | 2004-06-29 | 2006-01-05 | European Nickel Plc | Improved leaching of base metals |
| DE102005013967A1 (de) * | 2004-11-05 | 2006-10-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| WO2006071775A2 (en) * | 2004-12-29 | 2006-07-06 | Elan Pharmaceuticals, Inc. | Novel compounds useful for bradykinin b1 receptor antagonism |
| ES2360232T3 (es) | 2005-06-29 | 2011-06-02 | Compumedics Limited | Conjunto sensor con puente conductor. |
| WO2007101007A2 (en) * | 2006-02-23 | 2007-09-07 | Neurogen Corporation | Aryl sulfonyl heterocycles |
| TW200801513A (en) * | 2006-06-29 | 2008-01-01 | Fermiscan Australia Pty Ltd | Improved process |
| WO2008024692A1 (en) * | 2006-08-23 | 2008-02-28 | Neurogen Corporation | N-oxide aryl sulfones and sulfoxides |
| DE102007020493A1 (de) * | 2007-04-30 | 2008-11-06 | Grünenthal GmbH | Substituierte Amid-Derivate |
| EP2229394A1 (en) * | 2008-01-17 | 2010-09-22 | Grünenthal GmbH | Substituted sulfonamide derivatives |
| TW200940528A (en) * | 2008-03-05 | 2009-10-01 | Gruenenthal Gmbh | Substituted sulfonamide derivatives |
| TW201000464A (en) * | 2008-04-08 | 2010-01-01 | Gruenenthal Gmbh | Substituted sulfonamide derivatives |
| EP2262792A1 (de) * | 2008-04-08 | 2010-12-22 | Grünenthal GmbH | Substituierte sulfonamid-derivate |
| TW200944530A (en) * | 2008-04-09 | 2009-11-01 | Gruenenthal Chemie | Substituted sulfonamide derivatives |
-
2007
- 2007-09-27 PL PL07818500T patent/PL2066659T3/pl unknown
- 2007-09-27 RU RU2009115960/04A patent/RU2462464C2/ru not_active IP Right Cessation
- 2007-09-27 EP EP11006169A patent/EP2383267A1/de not_active Withdrawn
- 2007-09-27 SI SI200731301T patent/SI2066659T1/sl unknown
- 2007-09-27 WO PCT/EP2007/008417 patent/WO2008040492A1/de not_active Ceased
- 2007-09-27 CN CNA2007800436108A patent/CN101553481A/zh active Pending
- 2007-09-27 BR BRPI0714764-3A2A patent/BRPI0714764A2/pt not_active IP Right Cessation
- 2007-09-27 JP JP2009529606A patent/JP5405303B2/ja not_active Expired - Fee Related
- 2007-09-27 EP EP07818500.6A patent/EP2066659B1/de active Active
- 2007-09-27 KR KR1020097008960A patent/KR20090079914A/ko not_active Ceased
- 2007-09-27 NZ NZ575566A patent/NZ575566A/en not_active IP Right Cessation
- 2007-09-27 DK DK07818500.6T patent/DK2066659T3/da active
- 2007-09-27 MX MX2009003382A patent/MX2009003382A/es active IP Right Grant
- 2007-09-27 PT PT78185006T patent/PT2066659E/pt unknown
- 2007-09-27 CA CA002664810A patent/CA2664810A1/en not_active Abandoned
- 2007-09-27 ES ES07818500T patent/ES2436020T3/es active Active
- 2007-09-27 HR HRP20130958TT patent/HRP20130958T1/hr unknown
- 2007-09-27 AU AU2007304475A patent/AU2007304475B2/en not_active Ceased
- 2007-09-28 US US11/905,381 patent/US20080153843A1/en not_active Abandoned
-
2009
- 2009-03-26 IL IL197814A patent/IL197814A0/en unknown
- 2009-03-30 NO NO20091299A patent/NO20091299L/no not_active Application Discontinuation
- 2009-03-30 CO CO09032332A patent/CO6170358A2/es active IP Right Grant
- 2009-04-28 ZA ZA2009/02915A patent/ZA200902915B/en unknown
-
2010
- 2010-08-24 US US12/862,271 patent/US20100324009A1/en not_active Abandoned
- 2010-08-24 US US12/862,297 patent/US8435978B2/en not_active Expired - Fee Related
-
2013
- 2013-11-21 CY CY20131101046T patent/CY1114669T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0714764A2 (pt) | 2014-12-30 |
| US20080153843A1 (en) | 2008-06-26 |
| PT2066659E (pt) | 2013-11-07 |
| AU2007304475B2 (en) | 2012-07-26 |
| NO20091299L (no) | 2009-04-29 |
| CN101553481A (zh) | 2009-10-07 |
| CA2664810A1 (en) | 2008-04-10 |
| US20100317644A1 (en) | 2010-12-16 |
| JP2010504930A (ja) | 2010-02-18 |
| CY1114669T1 (el) | 2016-10-05 |
| AU2007304475A1 (en) | 2008-04-10 |
| ES2436020T3 (es) | 2013-12-26 |
| SI2066659T1 (sl) | 2013-10-30 |
| HK1132266A1 (en) | 2010-02-19 |
| US20100324009A1 (en) | 2010-12-23 |
| CO6170358A2 (es) | 2010-06-18 |
| EP2066659A1 (de) | 2009-06-10 |
| DK2066659T3 (da) | 2013-12-09 |
| NZ575566A (en) | 2011-05-27 |
| JP5405303B2 (ja) | 2014-02-05 |
| EP2383267A1 (de) | 2011-11-02 |
| MX2009003382A (es) | 2009-04-08 |
| PL2066659T3 (pl) | 2014-01-31 |
| ZA200902915B (en) | 2010-02-24 |
| KR20090079914A (ko) | 2009-07-22 |
| RU2462464C2 (ru) | 2012-09-27 |
| RU2009115960A (ru) | 2010-11-10 |
| EP2066659B1 (de) | 2013-08-28 |
| US8435978B2 (en) | 2013-05-07 |
| WO2008040492A1 (de) | 2008-04-10 |
| IL197814A0 (en) | 2009-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130958T1 (hr) | Supstituirani derivati sulfonamida | |
| RU2401265C2 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| CA2778484C (en) | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | |
| DE60210805T2 (de) | Substituierte indolizinähnliche verbindungen und ihre verwendung | |
| US10654849B2 (en) | (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| JP2021506858A5 (OSRAM) | ||
| RU2014154397A (ru) | Соединения тетрагидропиразолопиримидина | |
| JP2009538877A5 (OSRAM) | ||
| JP2019535664A5 (OSRAM) | ||
| RU2007102429A (ru) | Производные пиримидиномочевины в качестве ингибиторов киназ | |
| RU2018142987A (ru) | Положительные аллостерические модуляторы мускаринового ацетилхолинового рецептора m4 | |
| HRP20100378T1 (hr) | Spojevi triazolopirazina učinkoviti za tretman degenerativnih i upalnih bolesti | |
| AU2856900A (en) | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands | |
| CA2504160A1 (en) | Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds | |
| JP2013526536A5 (OSRAM) | ||
| KR20050096956A (ko) | 피라졸 유도체 | |
| AU2012318874A1 (en) | 1,3-substituted azetidine PDE10 inhibitors | |
| RU2020127848A (ru) | Производные 4-гидроксипиперидина и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19) | |
| US20130225583A1 (en) | Substituted amino-triazolyl pde10 inhibitors | |
| JP2019502680A5 (OSRAM) | ||
| JPWO2019215316A5 (OSRAM) | ||
| HRP20151036T1 (hr) | Novi derivati (heterocikal/tetrahidropiridin)-(piperazinil)-1-alkanon i (heterocikal/dihidropirolidin)-(piperazinil)-1-alkanon, i njihova uporaba kao inhibitora p75 | |
| HK1132266B (en) | Substituted sulfonamide derivatives | |
| JP2006512400A5 (OSRAM) | ||
| RU2021119602A (ru) | Фармацевтические композиции и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19) |